Xenobiology

Last updated

Xenobiology (XB) is a subfield of synthetic biology, the study of synthesizing and manipulating biological devices and systems. [1] The name "xenobiology" derives from the Greek word xenos, which means "stranger, alien". Xenobiology is a form of biology that is not (yet) familiar to science and is not found in nature. [2] In practice, it describes novel biological systems and biochemistries that differ from the canonical DNARNA-20 amino acid system (see central dogma of molecular biology). For example, instead of DNA or RNA, XB explores nucleic acid analogues, termed xeno nucleic acid (XNA) as information carriers. [3] It also focuses on an expanded genetic code [4] and the incorporation of non-proteinogenic amino acids, or “xeno amino acids” into proteins. [5] [6]

Contents

Difference between xeno-, exo-, and astro-biology

"Astro" means "star" and "exo" means "outside". Both exo- and astrobiology deal with the search for naturally evolved life in the Universe, mostly on other planets in the circumstellar habitable zone. (These are also occasionally referred to as xenobiology. [2] ) Whereas astrobiologists are concerned with the detection and analysis of life elsewhere in the Universe, xenobiology attempts to design forms of life with a different biochemistry or different genetic code than on planet Earth. [2]

Aims

Scientific approach

In xenobiology, the aim is to design and construct biological systems that differ from their natural counterparts on one or more fundamental levels. Ideally these new-to-nature organisms would be different in every possible biochemical aspect exhibiting a very different genetic code. [13] The long-term goal is to construct a cell that would store its genetic information not in DNA but in an alternative informational polymer consisting of xeno nucleic acids (XNA), different base pairs, using non-canonical amino acids and an altered genetic code. So far cells have been constructed that incorporate only one or two of these features.

Xeno nucleic acids (XNA)

Originally this research on alternative forms of DNA was driven by the question of how life evolved on earth and why RNA and DNA were selected by (chemical) evolution over other possible nucleic acid structures. [14] Two hypotheses for the selection of RNA and DNA as life's backbone are either they are favored under life on Earth's conditions, or they were coincidentally present in pre-life chemistry and continue to be used now. [15] Systematic experimental studies aiming at the diversification of the chemical structure of nucleic acids have resulted in completely novel informational biopolymers. So far a number of XNAs with new chemical backbones or leaving group of the DNA have been synthesized, [3] [16] [17] [18] e.g.: hexose nucleic acid (HNA); threose nucleic acid (TNA), [19] glycol nucleic acid (GNA) cyclohexenyl nucleic acid (CeNA). [20] The incorporation of XNA in a plasmid, involving 3 HNA codons, has been accomplished already in 2003. [21] This XNA is used in vivo (E coli) as template for DNA synthesis. This study, using a binary (G/T) genetic cassette and two non-DNA bases (Hx/U), was extended to CeNA, while GNA seems to be too alien at this moment for the natural biological system to be used as template for DNA synthesis. [22] Extended bases using a natural DNA backbone could, likewise, be transliterated into natural DNA, although to a more limited extent. [23]

Aside being used as extensions to template DNA strands, XNA activity has been tested for use as genetic catalysts. Although proteins are the most common components of cellular enzymatic activity, nucleic acids are also used in the cell to catalyze reactions. A 2015 study found several different kinds of XNA, most notably FANA (2'-fluoroarabino nucleic acids), as well as HNA, CeNA and ANA (arabino nucleic acids) could be used to cleave RNA during post-transcriptional RNA processing acting as XNA enzymes, hence the name XNAzymes. FANA XNAzymes also showed the ability to ligate DNA, RNA and XNA substrates. [15] Although XNAzyme studies are still preliminary, this study was a step in the direction of searching for synthetic circuit components that are more efficient than those containing DNA and RNA counterparts that can regulate DNA, RNA, and their own, XNA, substrates.

Expanding the genetic alphabet

While XNAs have modified backbones, other experiments target the replacement or enlargement of the genetic alphabet of DNA with unnatural base pairs. For example, DNA has been designed that has – instead of the four standard bases A, T, G, and C – six bases A, T, G, C, and the two new ones P and Z (where Z stands for 6-Amino-5-nitro3-(l'-p-D-2'-deoxyribofuranosyl)-2(1H)-pyridone, and P stands for 2-Amino-8-(1-beta-D-2'-deoxyribofuranosyl)imidazo[1,2-a]-1,3,5-triazin-4 (8H)). [24] [25] [26] In a systematic study, Leconte et al. tested the viability of 60 candidate bases (yielding potentially 3600 base pairs) for possible incorporation in the DNA. [27]

In 2002, Hirao et al. developed an unnatural base pair between 2-amino-8-(2-thienyl)purine (s) and pyridine-2-one (y) that functions in vitro in transcription and translation toward a genetic code for protein synthesis containing a non-standard amino acid. [28] In 2006, they created 7-(2-thienyl)imidazo[4,5-b]pyridine (Ds) and pyrrole-2-carbaldehyde (Pa) as a third base pair for replication and transcription, [29] and afterward, Ds and 4-[3-(6-aminohexanamido)-1-propynyl]-2-nitropyrrole (Px) was discovered as a high fidelity pair in PCR amplification. [30] [31] In 2013, they applied the Ds-Px pair to DNA aptamer generation by in vitro selection (SELEX) and demonstrated the genetic alphabet expansion significantly augment DNA aptamer affinities to target proteins. [32]

In May 2014, researchers announced that they had successfully introduced two new artificial nucleotides into bacterial DNA, alongside the four naturally occurring nucleotides, and by including individual artificial nucleotides in the culture media, were able to passage the bacteria 24 times; they did not create mRNA or proteins able to use the artificial nucleotides. [33] [34] [35]

Novel polymerases

Neither the XNA nor the unnatural bases are recognized by natural polymerases. One of the major challenges is to find or create novel types of polymerases that will be able to replicate these new-to-nature constructs. In one case a modified variant of the HIV-reverse transcriptase was found to be able to PCR-amplify an oligonucleotide containing a third type base pair. [36] [37] Pinheiro et al. (2012) demonstrated that the method of polymerase evolution and design successfully led to the storage and recovery of genetic information (of less than 100bp length) from six alternative genetic polymers based on simple nucleic acid architectures not found in nature, xeno nucleic acids. [38]

Genetic code engineering

One of the goals of xenobiology is to rewrite the genetic code. The most promising approach to change the code is the reassignment of seldom used or even unused codons. [39] In an ideal scenario, the genetic code is expanded by one codon, thus having been liberated from its old function and fully reassigned to a non-canonical amino acid (ncAA) ("code expansion"). As these methods are laborious to implement, and some short cuts can be applied ("code engineering"), for example in bacteria that are auxotrophic for specific amino acids and at some point in the experiment are fed isostructural analogues instead of the canonical amino acids for which they are auxotrophic. In that situation, the canonical amino acid residues in native proteins are substituted with the ncAAs. Even the insertion of multiple different ncAAs into the same protein is possible. [40] Finally, the repertoire of 20 canonical amino acids can not only be expanded, but also reduced to 19. [41] By reassigning transfer RNA (tRNA)/aminoacyl-tRNA synthetase pairs the codon specificity can be changed. Cells endowed with such aminoacyl-[tRNA synthetases] are thus able to read [mRNA] sequences that make no sense to the existing gene expression machinery. [42] Altering the codon: tRNA synthetases pairs may lead to the in vivo incorporation of the non-canonical amino acids into proteins. [43] [44] In the past reassigning codons was mainly done on a limited scale. In 2013, however, Farren Isaacs and George Church at Harvard University reported the replacement of all 321 TAG stop codons present in the genome of E. coli with synonymous TAA codons, thereby demonstrating that massive substitutions can be combined into higher-order strains without lethal effects. [45] Following the success of this genome wide codon replacement, the authors continued and achieved the reprogramming of 13 codons throughout the genome, directly affecting 42 essential genes. [46]

An even more radical change in the genetic code is the change of a triplet codon to a quadruplet and even quintuplet codon pioneered by Sisido in cell-free systems [47] and by Schultz in bacteria. [48] Finally, non-natural base pairs can be used to introduce novel amino acid in proteins. [49]

Directed evolution

The goal of substituting DNA by XNA may also be reached by another route, namely by engineering the environment instead of the genetic modules. This approach has been successfully demonstrated by Marlière and Mutzel with the production of an E. coli strain whose DNA is composed of standard A, C and G nucleotides but has the synthetic thymine analogue 5-chlorouracil instead of thymine (T) in the corresponding positions of the sequence. These cells are then dependent on externally supplied 5-chlorouracil for growth, but otherwise they look and behave as normal E. coli. These cells, however, are currently not yet fully auxotrophic for the Xeno-base since they are still growing on thymine when this is supplied to the medium. [50]

Biosafety

Xenobiological systems are designed to convey orthogonality to natural biological systems. A (still hypothetical) organism that uses XNA, [51] different base pairs and polymerases and has an altered genetic code will hardly be able to interact with natural forms of life on the genetic level. Thus, these xenobiological organisms represent a genetic enclave that cannot exchange information with natural cells. [52] Altering the genetic machinery of the cell leads to semantic containment. In analogy to information processing in IT, this safety concept is termed a “genetic firewall”. [2] [53] The concept of the genetic firewall seems to overcome a number of limitations of previous safety systems. [54] [55] A first experimental evidence of the theoretical concept of the genetic firewall was achieved in 2013 with the construction of a genomically recoded organism (GRO). In this GRO all known UAG stop codons in E.coli were replaced by UAA codons, which allowed for the deletion of release factor 1 and reassignment of UAG translation function. The GRO exhibited increased resistance to T7 bacteriophage, thus showing that alternative genetic codes do reduce genetic compatibility. [56] This GRO, however, is still very similar to its natural “parent” and cannot be regarded to have a genetic firewall. The possibility of reassigning the function of large number of triplets opens the perspective to have strains that combine XNA, novel base pairs, new genetic codes, etc. that cannot exchange any information with the natural biological world. Regardless of changes leading to a semantic containment mechanism in new organisms, any novel biochemical systems still has to undergo a toxicological screening. XNA, novel proteins, etc. might represent novel toxins, or have an allergic potential that needs to be assessed. [57] [58]

Governance and regulatory issues

Xenobiology might challenge the regulatory framework, as currently laws and directives deal with genetically modified organisms and do not directly mention chemically or genomically modified organisms. Taking into account that real xenobiology organisms are not expected in the next few years, policy makers do have some time at hand to prepare themselves for an upcoming governance challenge. Since 2012, the following groups have picked up the topic as a developing governance issue: policy advisers in the US, [59] four National Biosafety Boards in Europe, [60] the European Molecular Biology Organisation, [61] and the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) in three opinions (Definition, [62] risk assessment methodologies and safety aspects, [63] and risks to the environment and biodiversity related to synthetic biology and research priorities in the field of synthetic biology. [64] ).

See also

Related Research Articles

<span class="mw-page-title-main">Base pair</span> Unit consisting of two nucleobases bound to each other by hydrogen bonds

A base pair (bp) is a fundamental unit of double-stranded nucleic acids consisting of two nucleobases bound to each other by hydrogen bonds. They form the building blocks of the DNA double helix and contribute to the folded structure of both DNA and RNA. Dictated by specific hydrogen bonding patterns, "Watson–Crick" base pairs allow the DNA helix to maintain a regular helical structure that is subtly dependent on its nucleotide sequence. The complementary nature of this based-paired structure provides a redundant copy of the genetic information encoded within each strand of DNA. The regular structure and data redundancy provided by the DNA double helix make DNA well suited to the storage of genetic information, while base-pairing between DNA and incoming nucleotides provides the mechanism through which DNA polymerase replicates DNA and RNA polymerase transcribes DNA into RNA. Many DNA-binding proteins can recognize specific base-pairing patterns that identify particular regulatory regions of genes.

<span class="mw-page-title-main">Genetic code</span> Rules by which information encoded within genetic material is translated into proteins

The genetic code is the set of rules used by living cells to translate information encoded within genetic material into proteins. Translation is accomplished by the ribosome, which links proteinogenic amino acids in an order specified by messenger RNA (mRNA), using transfer RNA (tRNA) molecules to carry amino acids and to read the mRNA three nucleotides at a time. The genetic code is highly similar among all organisms and can be expressed in a simple table with 64 entries.

<span class="mw-page-title-main">Stop codon</span> Codon that marks the end of a protein-coding sequence

In molecular biology, a stop codon is a codon that signals the termination of the translation process of the current protein. Most codons in messenger RNA correspond to the addition of an amino acid to a growing polypeptide chain, which may ultimately become a protein; stop codons signal the termination of this process by binding release factors, which cause the ribosomal subunits to disassociate, releasing the amino acid chain.

<span class="mw-page-title-main">Central dogma of molecular biology</span> Explanation of the flow of genetic information within a biological system

The central dogma of molecular biology is an explanation of the flow of genetic information within a biological system. It is often stated as "DNA makes RNA, and RNA makes protein", although this is not its original meaning. It was first stated by Francis Crick in 1957, then published in 1958:

The Central Dogma. This states that once "information" has passed into protein it cannot get out again. In more detail, the transfer of information from nucleic acid to nucleic acid, or from nucleic acid to protein may be possible, but transfer from protein to protein, or from protein to nucleic acid is impossible. Information here means the precise determination of sequence, either of bases in the nucleic acid or of amino acid residues in the protein.

<span class="mw-page-title-main">Translation (biology)</span> Cellular process of protein synthesis

In biology, translation is the process in living cells in which proteins are produced using RNA molecules as templates. The generated protein is a sequence of amino acids. This sequence is determined by the sequence of nucleotides in the RNA. The nucleotides are considered three at a time. Each such triple results in addition of one specific amino acid to the protein being generated. The matching from nucleotide triple to amino acid is called the genetic code. The translation is performed by a large complex of functional RNA and proteins called ribosomes. The entire process is called gene expression.

<span class="mw-page-title-main">Transfer RNA</span> RNA that facilitates the addition of amino acids to a new protein

Transfer RNA is an adaptor molecule composed of RNA, typically 76 to 90 nucleotides in length, that serves as the physical link between the mRNA and the amino acid sequence of proteins. Transfer RNA (tRNA) does this by carrying an amino acid to the protein-synthesizing machinery of a cell called the ribosome. Complementation of a 3-nucleotide codon in a messenger RNA (mRNA) by a 3-nucleotide anticodon of the tRNA results in protein synthesis based on the mRNA code. As such, tRNAs are a necessary component of translation, the biological synthesis of new proteins in accordance with the genetic code.

<span class="mw-page-title-main">Nirenberg and Matthaei experiment</span>

The Nirenberg and Matthaei experiment was a scientific experiment performed in May 1961 by Marshall W. Nirenberg and his post-doctoral fellow, J. Heinrich Matthaei, at the National Institutes of Health (NIH). The experiment deciphered the first of the 64 triplet codons in the genetic code by using nucleic acid homopolymers to translate specific amino acids.

<span class="mw-page-title-main">Nirenberg and Leder experiment</span>

The Nirenberg and Leder experiment was a scientific experiment performed in 1964 by Marshall W. Nirenberg and Philip Leder. The experiment elucidated the triplet nature of the genetic code and allowed the remaining ambiguous codons in the genetic code to be deciphered.

<span class="mw-page-title-main">Synthetic biology</span> Interdisciplinary branch of biology and engineering

Synthetic biology (SynBio) is a multidisciplinary field of science that focuses on living systems and organisms, and it applies engineering principles to develop new biological parts, devices, and systems or to redesign existing systems found in nature.

<span class="mw-page-title-main">Gene</span> Sequence of DNA or RNA that codes for an RNA or protein product

In biology, the word gene has two meanings. The Mendelian gene is a basic unit of heredity. The molecular gene is a sequence of nucleotides in DNA, that is transcribed to produce a functional RNA. There are two types of molecular genes: protein-coding genes and non-coding genes.

Threose nucleic acid (TNA) is an artificial genetic polymer in which the natural five-carbon ribose sugar found in RNA has been replaced by an unnatural four-carbon threose sugar. Invented by Albert Eschenmoser as part of his quest to explore the chemical etiology of RNA, TNA has become an important synthetic genetic polymer (XNA) due to its ability to efficiently base pair with complementary sequences of DNA and RNA. The main difference between TNA and DNA/RNA is their backbones. DNA and RNA have their phosphate backbones attached to the 5' carbon of the deoxyribose or ribose sugar ring, respectively. TNA, on the other hand, has it's phosphate backbone directly attached to the 3' carbon in the ring, since it does not have a 5' carbon. This modified backbone makes TNA, unlike DNA and RNA, completely refractory to nuclease digestion, making it a promising nucleic acid analog for therapeutic and diagnostic applications.

Steven Albert Benner is an American chemist. He has been a professor at Harvard University, ETH Zurich, and most recently at the University of Florida, where he was the V.T. & Louise Jackson Distinguished Professor of Chemistry. In 2005, he founded The Westheimer Institute of Science and Technology (TWIST) and the Foundation For Applied Molecular Evolution. Benner has also founded the companies EraGen Biosciences and Firebird BioMolecular Sciences LLC.

Missense mRNA is a messenger RNA bearing one or more mutated codons that yield polypeptides with an amino acid sequence different from the wild-type or naturally occurring polypeptide. Missense mRNA molecules are created when template DNA strands or the mRNA strands themselves undergo a missense mutation in which a protein coding sequence is mutated and an altered amino acid sequence is coded for.

<span class="mw-page-title-main">Nucleic acid analogue</span> Compound analogous to naturally occurring RNA and DNA

Nucleic acid analogues are compounds which are analogous to naturally occurring RNA and DNA, used in medicine and in molecular biology research. Nucleic acids are chains of nucleotides, which are composed of three parts: a phosphate backbone, a pentose sugar, either ribose or deoxyribose, and one of four nucleobases. An analogue may have any of these altered. Typically the analogue nucleobases confer, among other things, different base pairing and base stacking properties. Examples include universal bases, which can pair with all four canonical bases, and phosphate-sugar backbone analogues such as PNA, which affect the properties of the chain . Nucleic acid analogues are also called xeno nucleic acids and represent one of the main pillars of xenobiology, the design of new-to-nature forms of life based on alternative biochemistries.

<span class="mw-page-title-main">Expanded genetic code</span> Modified genetic code

An expanded genetic code is an artificially modified genetic code in which one or more specific codons have been re-allocated to encode an amino acid that is not among the 22 common naturally-encoded proteinogenic amino acids.

<span class="mw-page-title-main">DNA and RNA codon tables</span> List of standard rules to translate DNA encoded information into proteins

A codon table can be used to translate a genetic code into a sequence of amino acids. The standard genetic code is traditionally represented as an RNA codon table, because when proteins are made in a cell by ribosomes, it is messenger RNA (mRNA) that directs protein synthesis. The mRNA sequence is determined by the sequence of genomic DNA. In this context, the standard genetic code is referred to as translation table 1. It can also be represented in a DNA codon table. The DNA codons in such tables occur on the sense DNA strand and are arranged in a 5-to-3 direction. Different tables with alternate codons are used depending on the source of the genetic code, such as from a cell nucleus, mitochondrion, plastid, or hydrogenosome.

An alloprotein is a novel synthetic protein containing one or more "non-natural" amino acids. Non-natural in the context means an amino acid either not occurring in nature, or occurring in nature but not naturally occurring within proteins.

<span class="mw-page-title-main">Xeno nucleic acid</span> Synthetic nucleic acid analogues

Xeno nucleic acids (XNA) are synthetic nucleic acid analogues that have a different backbone than the ribose and deoxyribose found in the nucleic acids of naturally occurring RNA and DNA.

<span class="mw-page-title-main">Nediljko Budisa</span>

Nediljko "Ned" Budisa is a Croatian biochemist, professor and holder of the Tier 1 Canada Research Chair (CRC) for chemical synthetic biology at the University of Manitoba. As pioneer in the areas of genetic code engineering and chemical synthetic biology (Xenobiology), his research has a wide range of applications in biotechnology and engineering biology in general. Being highly interdisciplinary, it includes bioorganic and medical chemistry, structural biology, biophysics and molecular biotechnology as well as metabolic and biomaterial engineering. He is the author of the only textbook in his research field: “Engineering the genetic code: expanding the amino acid repertoire for the design of novel proteins”.

<span class="mw-page-title-main">Hachimoji DNA</span> Synthetic DNA

Hachimoji DNA is a synthetic nucleic acid analog that uses four synthetic nucleotides in addition to the four present in the natural nucleic acids, DNA and RNA. This leads to four allowed base pairs: two unnatural base pairs formed by the synthetic nucleobases in addition to the two normal pairs. Hachimoji bases have been demonstrated in both DNA and RNA analogs, using deoxyribose and ribose respectively as the backbone sugar.

References

  1. Budisa, Nediljko; Kubyshkin, Vladimir; Schmidt, Markus (22 April 2020). "Xenobiology: A Journey towards Parallel Life Forms". ChemBioChem. 21 (16): 2228–2231. doi: 10.1002/cbic.202000141 . PMID   32323410.
  2. 1 2 3 4 5 Schmidt, Markus (9 March 2010). "Xenobiology: A new form of life as the ultimate biosafety tool". BioEssays. 32 (4): 322–31. doi:10.1002/bies.200900147. PMC   2909387 . PMID   20217844.
  3. 1 2 Pinheiro, V.B.; Holliger, P. (2012). "The XNA world: Progress towards replication and evolution of synthetic genetic polymers". Current Opinion in Chemical Biology. 16 (3–4): 245–52. doi:10.1016/j.cbpa.2012.05.198. PMID   22704981.
  4. Bain, J. D.; Switzer, C.; Chamberlin, R.; Benner, Steven A. (1992). "Ribosome-mediated incorporation of a non-standard amino acid into a peptide through expansion of the genetic code". Nature. 356 (6369): 537–39. Bibcode:1992Natur.356..537B. doi:10.1038/356537a0. PMID   1560827. S2CID   4286160.
  5. Noren, C.J.; Anthony-Cahill, S.J.; Griffith, M.C.; Schultz, P.G. (1989). "A general method for site-specific incorporation of unnatural amino acids into proteins". Science. 244 (4901): 182–88. Bibcode:1989Sci...244..182N. doi:10.1126/science.2649980. PMID   2649980.
  6. Brown, Sean M.; Mayer-Bacon, Christopher; Freeland, Stephen (December 2023). "Xeno Amino Acids: A Look into Biochemistry as We Do Not Know It". Life. 13 (12): 2281. Bibcode:2023Life...13.2281B. doi: 10.3390/life13122281 . ISSN   2075-1729. PMC   10744825 . PMID   38137883.
  7. Pace, NR (2001). "The universal nature of biochemistry". Proc Natl Acad Sci USA. 98 (3): 805–08. Bibcode:2001PNAS...98..805P. doi: 10.1073/pnas.98.3.805 . PMC   33372 . PMID   11158550.
  8. Wiltschi, B. and N. Budisa, "Natural history and experimental evolution of the genetic code". Applied Microbiology and Biotechnology, 2007. 74: pp. 739–53
  9. Berg, Jeremy M.; Tymoczko, John L.; Stryer, Lubert (2013). Stryer Biochemie. doi:10.1007/978-3-8274-2989-6. ISBN   978-3-8274-2988-9.
  10. "Metacode - Home". Metacode. Archived from the original on October 19, 2016. Retrieved October 18, 2016.
  11. Kubyshkin, V.; Acevedo-Rocha, C. G.; Budisa, N. (2017). "On universal coding events in protein biogenesis". Biosystems. 164: 16–25. doi: 10.1016/j.biosystems.2017.10.004 . PMID   29030023.
  12. Herdewijn, P; Marlière, P (Jun 2009). "Toward safe genetically modified organisms through the chemical diversification of nucleic acids". Chemistry & Biodiversity. 6 (24): 791–808. doi:10.1002/cbdv.200900083. PMID   19554563. S2CID   8572188.
  13. Kubyshkin, V.; Budisa, N. (2017). "Synthetic alienation of microbial organisms by using genetic code engineering: Why and how?". Biotechnology Journal. 12 (8): 1600097. doi:10.1002/biot.201600097. PMID   28671771.
  14. Eschenmoser, A (1999). "Chemical etiology of nucleic acid structure" (PDF). Science. 284 (5423): 2118–24. doi:10.1126/science.284.5423.2118. PMID   10381870.
  15. 1 2 Taylor, Alexander I.; Pinheiro, Vitor B.; Smola, Matthew J.; Morgunov, Alexey S.; Peak-Chew, Sew; Cozens, Christopher; Weeks, Kevin M.; Herdewijn, Piet; Holliger, Philipp (2015). "Catalysts from synthetic genetic polymers". Nature. 518 (7539): 427–30. Bibcode:2015Natur.518..427T. doi:10.1038/nature13982. PMC   4336857 . PMID   25470036.
  16. Vastmans, K; Froeyen, M; Kerremans, L; et al. (2001). "Reverse transcriptase incorporation of 1,5-anhydrohexitol nucleotides". Nucleic Acids Res. 29 (15): 3154–63. doi:10.1093/nar/29.15.3154. PMC   55830 . PMID   11470872.
  17. Jang, M; et al. (2013). "A synthetic substrate of DNA polymerase deviating from the bases, sugar, and leaving group of canonical deoxynucleoside triphosphates". Chemistry & Biology. 20 (3): 416–23. doi: 10.1016/j.chembiol.2013.02.010 . PMID   23521798.
  18. Pinheiro, V.B.; Loakes, D.; Holliger, P. (2013). "Synthetic polymers and their potential as genetic materials". BioEssays. 35 (2): 113–22. doi:10.1002/bies.201200135. PMID   23281109. S2CID   205475355.
  19. Ichida, JK; Horhota, A; Zou, K; et al. (2005). "High fidelity TNA synthesis by Therminator polymerase". Nucleic Acids Research. 33 (16): 5219–25. doi:10.1093/nar/gki840. PMC   1214552 . PMID   16157867.
  20. Kempeneers, V; Renders, M; Froeyen, M; et al. (2005). "Investigation of the DNA-dependent cyclohexenyl nucleic acid polymerization and the cyclohexenyl nucleic acid-dependent DNA polymerization". Nucleic Acids Res. 33 (12): 3828–36. doi:10.1093/nar/gki695. PMC   1175020 . PMID   16027107.
  21. Pochet, S.; et al. (2003). "Replication of hexitol oligonucleotides as a prelude to the propagation of a third type of nucleic acid in vivo". Comptes Rendus Biologies. 326 (12): 1175–84. doi:10.1016/j.crvi.2003.10.004. PMID   14746272.
  22. Pezo, Valérie; Liu, Feng Wu; Abramov, Mikhail; Froeyen, Mathy; Herdewijn, Piet; Marlière, Philippe (2013). "Binary Genetic Cassettes for Selecting XNA-Templated DNA Synthesis in Vivo". Angewandte Chemie International Edition. 52 (31): 8139–43. doi:10.1002/anie.201303288. PMID   23804524. S2CID   205375077.
  23. Krueger, AT.; et al. (2011). "Encoding Phenotype in Bacteria with an Alternative Genetic Set". J. Am. Chem. Soc. 133 (45): 18447–51. doi:10.1021/ja208025e. PMC   3255458 . PMID   21981660.
  24. Sismour, A.M.; et al. (2004). "PCR amplification of DNA containing non-standard base pairs by variants of reverse transcriptase from Human Immunodeficiency Virus-1". Nucleic Acids Research. 32 (2): 728–35. doi:10.1093/nar/gkh241. PMC   373358 . PMID   14757837.
  25. Yang, Z.; Hutter, D.; Sheng, P.; Sismour, A.M.; Benner, S.A. (2006). "Artificially expanded genetic information system: a new base pair with an alternative hydrogen bonding pattern". Nucleic Acids Research. 34 (21): 6095–101. doi:10.1093/nar/gkl633. PMC   1635279 . PMID   17074747.
  26. Yang, Z.; Sismour, A.M.; Sheng, P.; Puskar, N.L.; Benner, S.A. (2007). "Enzymatic incorporation of a third nucleobase pair". Nucleic Acids Research. 35 (13): 4238–49. doi:10.1093/nar/gkm395. PMC   1934989 . PMID   17576683.
  27. Leconte, A.M.; Hwang, G.T.; Matsuda, S.; Capek, P.; Hari, Y.; Romesberg, F.E. (2008). "Discovery, characterization, and optimization of an unnatural base pair for expansion of the genetic alphabet". J. Am. Chem. Soc. 130 (7): 2336–43. doi:10.1021/ja078223d. PMC   2892755 . PMID   18217762.
  28. Hirao, I.; et al. (2002). "An unnatural base pair for incorporating amino acid analogs into proteins". Nat. Biotechnol. 20 (2): 177–82. doi:10.1038/nbt0202-177. PMID   11821864. S2CID   22055476.
  29. Hirao, I.; et al. (2006). "An unnatural hydrophobic base pair system: site-specific incorporation of nucleotide analogs into DNA and RNA". Nat. Methods. 6 (9): 729–35. doi:10.1038/nmeth915. PMID   16929319. S2CID   6494156.
  30. Kimoto, M.; et al. (2009). "An unnatural base pair system for efficient PCR amplification and functionalization of DNA molecules". Nucleic Acids Research. 37 (2): e14. doi:10.1093/nar/gkn956. PMC   2632903 . PMID   19073696.
  31. Yamashige, R.; et al. (2012). "Highly specific unnatural base pair systems as a third base pair for PCR amplification". Nucleic Acids Research. 40 (6): 2793–2806. doi:10.1093/nar/gkr1068. PMC   3315302 . PMID   22121213.
  32. Kimoto, M.; et al. (2013). "Generation of high-affinity DNA aptamers using an expanded genetic alphabet". Nat. Biotechnol. 31 (5): 453–57. doi:10.1038/nbt.2556. PMID   23563318. S2CID   23329867.
  33. Pollack, Andrew (May 7, 2014). "Researchers Report Breakthrough in Creating Artificial Genetic Code". New York Times . Retrieved May 7, 2014.
  34. Callaway, Ewen (May 7, 2014). "First life with 'alien' DNA". Nature . doi:10.1038/nature.2014.15179. S2CID   86967999 . Retrieved May 7, 2014.
  35. Malyshev, Denis A.; Dhami, Kirandeep; Lavergne, Thomas; Chen, Tingjian; Dai, Nan; Foster, Jeremy M.; Corrêa, Ivan R.; Romesberg, Floyd E. (May 7, 2014). "A semi-synthetic organism with an expanded genetic alphabet". Nature . 509 (7500): 385–88. Bibcode:2014Natur.509..385M. doi:10.1038/nature13314. PMC   4058825 . PMID   24805238.
  36. Sismour, A.M.; Benner, S.A. (2005). "The use of thymidine analogs to improve the replication of an extra DNA base pair: a synthetic biological system". Nucleic Acids Research. 33 (17): 5640–46. doi:10.1093/nar/gki873. PMC   1236980 . PMID   16192575.
  37. Havemann, S.A.; Hoshika, S.; Hutter, D.; Benner, S.A. (2008). "Incorporation of multiple sequential pseudothymidines by DNA polymerases and their impact on DNA duplex structure". Nucleosides Nucleotides Nucleic Acids. 27 (3): 261–78. doi:10.1080/15257770701853679. PMID   18260010. S2CID   13771636.
  38. Pinheiro, VB; et al. (2012). "Synthetic genetic polymers capable of heredity and evolution". Science. 336 (6079): 341–44. Bibcode:2012Sci...336..341P. doi:10.1126/science.1217622. PMC   3362463 . PMID   22517858.
  39. Budisa, N. (2005). Engineering the Genetic Code – Expanding the Amino Acid Repertoire for the Design of Novel Proteins, Wiley-VHC Weinheim, New York, Brisbane, Singapore, Toronto
  40. Hoesl, M. G.; Budisa, N. (2012). "Recent advances in genetic code engineering in Escherichia coli". Curr. Opin. Biotechnol. 23 (5): 751–57. doi:10.1016/j.copbio.2011.12.027. PMID   22237016.
  41. Pezo, V.; Guérineau, V.; Le Caer, J.-P.; Faillon, L.; Mutzel, R.; Marlière, P. (2013). "A metabolic prototype for eliminating tryptophan from the genetic code". Scientific Reports. 3: 1359. Bibcode:2013NatSR...3E1359P. doi:10.1038/srep01359. PMC   3584311 . PMID   23447021.
  42. Rackham, O.; Chin, J.W. (2005). "A network of orthogonal ribosome mRNA pairs. Nat". Chem. Biol. 1 (3): 159–66. doi:10.1038/nchembio719. PMID   16408021. S2CID   37181098.
  43. Wang, L.; Brock, A.; Herberich, B.; Schultz, P.G. (2001). "Expanding the genetic code of Escherichia coli". Science. 292 (5516): 498–500. Bibcode:2001Sci...292..498W. doi:10.1126/science.1060077. PMID   11313494. S2CID   6702011.
  44. Hartman, M.C.; Josephson, K.; Lin, C.W.; Szostak, J.W. (2007). "An expanded set of amino acid analogs for the ribosomal translation of unnatural peptides". PLOS ONE. 2 (10): e972. Bibcode:2007PLoSO...2..972H. doi: 10.1371/journal.pone.0000972 . PMC   1989143 . PMID   17912351.
  45. Lajoie, MJ; et al. (2013). "Genomically Recoded Organisms Expand Biological Functions". Science. 342 (6156): 357–60. Bibcode:2013Sci...342..357L. doi:10.1126/science.1241459. PMC   4924538 . PMID   24136966.
  46. Lajoie, MJ; Kosuri, S; Mosberg, JA; Gregg, CJ; Zhang, D; Church, GM (2013). "Probing the Limits of Genetic Recoding in Essential Genes". Science. 342 (6156): 361–63. Bibcode:2013Sci...342..361L. doi:10.1126/science.1241460. PMID   24136967. S2CID   3211613.
  47. Hohsaka, T; Sisido, M (2002). "Incorporation of non-natural amino acids into proteins". Curr. Opin. Chem. Biol. 6 (10): 809–15. doi:10.1016/s1367-5931(02)00376-9. PMID   12470735.
  48. Anderson, J.C.; Wu, N.; Santoro, S.W.; Lakshman, V.; King, D.S.; Schultz, P.G. (2004). "An expanded genetic code with a functional quadruplet codon". Proc. Natl. Acad. Sci. USA. 101 (20): 7566–71. Bibcode:2004PNAS..101.7566A. doi: 10.1073/pnas.0401517101 . PMC   419646 . PMID   15138302.
  49. Hirao, I; Ohtsuki, T; Fujiwara, T; Mitsui, T; Yokogawa, T; Okuni, T; Nakayama, H; Takio, K; Yabuki, T; Kigawa, T; Kodama, K; Yokogawa, T; Nishikawa, K; Yokoyama, S (2002). "An unnatural base pair for incorporating amino acid analogs into proteins". Nat. Biotechnol. 20 (2): 177–82. doi:10.1038/nbt0202-177. PMID   11821864. S2CID   22055476.
  50. Marlière, P.; et al. (2011). "Chemical Evolution of a Bacterium's Genome". Angewandte Chemie International Edition. 50 (31): 7109–14. doi:10.1002/anie.201100535. PMID   21710668.
  51. Herdewijn, P. and Marlière, P. (2009) Toward safe genetically modified organisms through the chemical diversification of nucleic acids. Chem. Biodivers. 6, 791–808
  52. Marlière, P (2009). "The farther, the safer: a manifesto for securely navigating synthetic species away from the old living world". Syst. Synth. Biol. 3 (1–4): 77–84. doi:10.1007/s11693-009-9040-9. PMC   2759432 . PMID   19816802.
  53. Acevedo-Rocha, CG; Budisa, N (2011). "On the Road towards Chemically Modified Organisms Endowed with a Genetic Firewall". Angewandte Chemie International Edition. 50 (31): 6960–62. doi:10.1002/anie.201103010. PMID   21710510.
  54. Moe-Behrens, GH; Davis, R; Haynes, KA (2013). "Preparing synthetic biology for the world". Front Microbiol. 4: 5. doi: 10.3389/fmicb.2013.00005 . PMC   3554958 . PMID   23355834.
  55. Wright, O; Stan, GB; Ellis, T (2013). "Building-in biosafety for synthetic biology". Microbiology. 159 (7): 1221–35. doi: 10.1099/mic.0.066308-0 . PMID   23519158.[ permanent dead link ]
  56. Lajoie, MJ; et al. (2013). "Genomically Recoded Organisms Expand Biological Functions". Science. 342 (6156): 357–60. Bibcode:2013Sci...342..357L. doi:10.1126/science.1241459. PMC   4924538 . PMID   24136966.
  57. Schmidt M, Pei L. 2011. Synthetic Toxicology: Where engineering meets biology and toxicology Toxicological Sciences 120(S1), S204–24
  58. Schmidt M. 2013. Safeguarding the Genetic Firewall with Xenobiology. In: ISGP. 2013. 21st Century Borders/Synthetic Biology: Focus on Responsibility and Governance.
  59. ISGP. 2013. 21st Century Borders/Synthetic Biology: Focus on Responsibility and Governance Archived December 2, 2013, at the Wayback Machine pp. 55–65
  60. Pauwels, K.; et al. (2013). "Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology". Journal für Verbraucherschutz und Lebensmittelsicherheit. 8 (3): 215–26. doi: 10.1007/s00003-013-0829-9 . S2CID   8412183.
  61. Garfinkel M. (2013) Biological containment of synthetic microorganisms: science and policy. Report on a ESF/LESC Strategic Workshop
  62. Vermeire T. et al. 2014. Final Opinion on Synthetic Biology: Definition. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)
  63. Vermeire T. et al. 2015. Final Opinion on Synthetic Biology II: Risk assessment methodologies and safety aspects. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)
  64. Vermeire T. et al. 2015. Final Opinion on Synthetic Biology III: Risks to the environment and biodiversity related to synthetic biology and research priorities in the field of synthetic biology. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)